1-4 of 4
Kerry S. Campbell, PhD
Close
Sort by
Journal Articles

Pembrolizumab and Copanlisib for the Treatment of Relapsed or Refractory Mature T-Cell Lymphomas

Stefan K. Barta, MD MRCP, MS, Nathan H. Fowler, MD, Jasmine Zain, MD, Jia Ruan, MD PhD, Sonali M. Smith, MD, Stephen J. Schuster, MD, Sunita D Nasta, MD, Jakub Svoboda, MD, James N Gerson, MD, Daniel J. Landsburg, MD, Elise A. Chong, MD, Henry C. Fung, FRCP,MBBChir, Kerry S Campbell, PhD, Nadia Khan, MD, Richard I. Fisher, MD, Carlyn Rose Tan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4031.
https://doi.org/10.1182/blood-2019-125385
Published: 2019
Journal Articles

The Phenotype of Natural Killer (NK) Cells in Multiple Myeloma (MM) Patients: Impact on Ex Vivo Responsiveness to the Anti-SLAMF7 Antibody, Elotuzumab

Tatiana Pazina, MS, BS, Alexander MacFarlane, PhD, Ashley Mentik-James, PhD, Clinton Yam, MBBS, Rebecca Kotcher, BA, Kerry S. Campbell, PhD BSPharm, Adam D. Cohen, MD
Journal: Blood
Blood (2015) 126 (23): 3024.
https://doi.org/10.1182/blood.V126.23.3024.3024
Published: 2015
Journal Articles

Enhancing the Cytotoxicity of NK Cells Toward Multiple Myeloma Using an Antibody Specific to SLAMF7

Tatiana Pazina, Ashley M James, PhD, Adam D. Cohen, MD, Kerry S. Campbell, PhD
Journal: Blood
Blood (2014) 124 (21): 2092.
https://doi.org/10.1182/blood.V124.21.2092.2092
Published: 2014
Journal Articles

Natural Killer Cell Dysfunction in Chronic Lymphocytic Leukemia Is Associated with Loss of the Mature KIR3DL1 + Subset

Alexander W. MacFarlane, PhD, Mowafaq Jillab, MD, Mitchell R Smith, MD PhD, R. Katherine Alpaugh, PhD, Marion E. Cole, MD, Samuel Litwin, PhD, Michael M. Millenson, MD, Tahseen I. Al-Saleem, MD, Adam D. Cohen, MD, Kerry S. Campbell, PhD
Journal: Blood
Blood (2014) 124 (21): 3318.
https://doi.org/10.1182/blood.V124.21.3318.3318
Published: 2014